tinnitus clinical trial otonomy

Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-313 for Tinnitus

SAN DIEGO, CALIFORNIA — Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, announced positive top-line results from the Phase 1/2 clinical trial of OTO-313 in patients with persistent tinnitus of at least moderate severity. The exploratory efficacy cohort of the trial included 31 evaluable patients randomized to a single…

Read More
cochlear podcast

Cochlear Launches New Hearing Health Today Podcast

Cochlear Limited the global leader in implantable hearing solutions, today announced a new podcast for hearing health professionals, Hearing Health Today. The podcast is an educational and thought-provoking series that explores the key challenges, trends and opportunities in the delivery of hearing care today, and into the future. The fortnightly podcast will feature hearing health experts…

Read More
inner ear stem cell research

USC Stem Cell Researchers Find Simpler Way to Make Inner Ear Hair Cells

LOS ANGELES, CALIFORNIA — Scientists from the USC Stem Cell laboratories of Neil Segil and Justin Ichida have found a simpler way to generate the sensory cells of the inner ear. Their approach uses direct reprogramming to produce sensory cells known as “hair cells,” due to their hair-like protrusions that sense sound waves.  The study was published this…

Read More
university audiology programs

Academic Leader Offers Insights to University Audiology Programs in a Post-Pandemic World

Entrepreneurs like Mark Cuban or Scott Galloway of the NYU Stern School of Business know that while the world is topsy-turvy for many people these days, it might be an ideal time to start a new business or embark on a potentially life-changing project. But, what about the prospects for those in academic audiology? The…

Read More
acclaim cochlear implant envoy

Envoy Medical Receives FDA Breakthrough Device Designation for Fully Implanted Acclaim® Cochlear Implant

WHITE BEAR LAKE, MINNESOTA — Envoy Medical® Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, today announced that its fully implanted Acclaim® cochlear implant was granted the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). Unlike existing traditional cochlear implants that are partially implanted and…

Read More
qm2 telehealth audiology

QM2 Solutions and ENT Hearing Associates of Florida Team Up on E-Visit Strategy

In early April, shortly after the onset of the COVID-19 pandemic, and because of an urgent need to extend contactless to patients, ENT Hearing Associates  of  Florida,  contracted with  QM2  Solutions  to provide an e-visit care option. Dr. Patricia Ramos, the Director of ENT Hearing Associates of Florida, used QM2 Solution’s SEngage to remotely connect…

Read More
akouos gene therapy hearing loss treatment

Akouos More Than Doubles Original IPO Goal, Raises $213M in First Day of Trading

BOSTON, MASSACHUSSETTS — After originally filing for an initial public offer (IPO) with the US Securities and Exchange Commission (SEC) earlier this month, eyeing a $100M IPO, gene therapy startup Akouos significantly exceeded its original expectations on Friday by raising $213M. The company sold 12.5 million shares for $17 each, above its anticipated range of…

Read More
haptic prosthetic cochlear implant

Researchers Find Enhanced Pitch Discrimination for Cochlear Implant Users with New Haptic Neuroprosthetic Device

In a new study, researchers examined the ability of a novel device to enhance pitch discrimination among cochlear implant users. The device, the mosaicOne_B, was designed to help provide missing pitch information to the wearer through haptic (tactile) stimulation on the forearm. This enhanced pitch discrimination “has the potential to significantly improve music perception, speech…

Read More